Vaxxitek HVT+IBD

RSS

Infectious bursal disease and Marek's disease vaccine (live recombinant)

Authorised
This medicine is authorised for use in the European Union.

Overview

Vaxxitek HVT+IBD is a veterinary vaccine used to protect chickens against infectious bursal disease (IBD, also known as Gumboro disease) and Marek’s disease.

Vaxxitek HVT+IBD is used to prevent the deaths of chickens and to reduce clinical signs and effects of IBD, a disease which damages the immune system of chickens. Vaxxitek HVT+IBD is also used to reduce mortality, clinical signs and effects of Marek's disease, a herpes virus infection of chickens.

This EPAR was last updated on 17/02/2021

Authorisation details

Product details
Name
Vaxxitek HVT+IBD
Agency product number
EMEA/V/C/000065
Active substance
Recombinant turkey herpesvirus, strain vhvt013-69, live
International non-proprietary name (INN) or common name
Infectious bursal disease and Marek's disease vaccine (live recombinant)
Species
  • Embryonated eggs
  • Chicken
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI01AD15
Publication details
Marketing-authorisation holder
Boehringer Ingelheim Vetmedica GmbH
Revision
14
Date of issue of marketing authorisation valid throughout the European Union
09/08/2002
Contact address

Binger Strasse 173
55216 Ingelheim am Rhein
Germany

Product information

06/01/2021 Vaxxitek HVT+IBD - EMEA/V/C/000065 - IB/0035

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Immunologicals for aves

  • Domestic fowl

  • Immunologicals

Therapeutic indication

For active immunisation of chickens:

  • To prevent mortality and to reduce clinical signs and lesions of Infectious Bursal disease.
  • To reduce mortality, clinical signs and lesions of Marek's disease.

Assessment history

How useful was this page?

Add your rating
Average
1 rating
1 rating